Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Age of Diagnosis of Breast Cancer in China: Almost 10 Years Earlier than in the United States and the European Union

  • Song, Qing-Kun (Beijing Key Laboratory of Cancer Therapeutic Vaccine, Beijing Shijitan Hospital, Capital Medical University) ;
  • Li, Jing (Department of Cancer Epidemiology, Chinese Academy of Medical Sciences & Peking Union Medical College) ;
  • Huang, Rong (Department of Epidemiology, West China School of Public Health, Sichuan University) ;
  • Fan, Jin-Hu (Department of Cancer Epidemiology, Chinese Academy of Medical Sciences & Peking Union Medical College) ;
  • Zheng, Rong-Shou (National Office for Cancer Prevention and Control & National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College) ;
  • Zhang, Bao-Ning (Center of Breast Disease, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College) ;
  • Zhang, Bin (Department of Breast Surgery, Liaoning Cancer Hospital) ;
  • Tang, Zhong-Hua (Department of Breast-thyroid Surgery, Xiangya Sencod Hospital, Central South University) ;
  • Xie, Xiao-Ming (Department of Breast Oncology, Sun Yat-Sen University Cancer Center) ;
  • Yang, Hong-Jian (Department of Breast Surgery, Zhejiang Cancer Hospital) ;
  • He, Jian-Jun (Department of Oncosurgery, the First Affiliated Hospital of Medical College, Xi'an JiaoTong University) ;
  • Li, Hui (Department of Breast Surgery, the Second People's Hospital of Sichuan Province) ;
  • Li, Jia-Yuan ;
  • Qiao, You-Lin (Department of Cancer Epidemiology, Chinese Academy of Medical Sciences & Peking Union Medical College) ;
  • Chen, Wan-Qing (National Office for Cancer Prevention and Control & National Central Cancer Registry, Chinese Academy of Medical Sciences & Peking Union Medical College)
  • Published : 2014.12.18
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The study aimed to describe the age distribution of breast cancer diagnosis among Chinese females for comparison with the United States and the European Union, and provide evidence for the screening target population in China. Materials and Methods: Median age was estimated from hospital databases from 7 tertiary hospitals in China. Population-based data in China, United States and European Union was extracted from the National Central Cancer Registry, SEER program and GLOBOCAN 2008, respectively. Age-standardized distribution of breast cancer at diagnosis in the 3 areas was estimated based on the World Standard Population 2000. Results: The median age of breast cancer at diagnosis was around 50 in China, nearly 10 years earlier than United States and European Union. The diagnosis age in China did not vary between subgroups of calendar year, region and pathological characteristics. With adjustment for population structure, median age of breast cancer at diagnosis was 50~54 in China, but 55~59 in United States and European Union. Conclusions: The median diagnosis age of female breast cancer is much earlier in China than in the United States and the European Union pointing to racial differences in genetics and lifestyle. Screening programs should start at an earlier age for Chinese women and age disparities between Chinese and Western women warrant further studies.

Keywords

References

  1. American Joint Committee on Cancer (1997). AJCC Cancer staging Manual, Philadelphia, Lippincott-Raven.
  2. American joint committee on cancer (2002). AJCC Cancer staging Manual, New York, Springer.
  3. Ahmad OB, Boschi-Pinto C, Lopez AD, et al 2001. Age standardization of rates: A New WHO Standard, Geneva, World Health Organization.
  4. Bratton MR, Frigo DE, Segar HC, et al (2012). The organochlorine o, p'-DDT Plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells. Environ Health Perspect, 120, 1291-6. https://doi.org/10.1289/ehp.1104296
  5. Brody JG, Rudel RA (2003). Environmental pollutants and breast cancer. Environ Health Perspect, 111, 1007-19. https://doi.org/10.1289/ehp.6310
  6. Caldarella A, Crocetti E, Bianchi S, et al (2011). Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res, 17, 753-8. https://doi.org/10.1007/s12253-011-9381-z
  7. de Bruin MA, Kwong A, Goldstein BA, et al (2011). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. Fam Cancer, 11, 429-39.
  8. Deapen D, Liu L, Perkins C, et al (2002). Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer, 99, 747-50. https://doi.org/10.1002/ijc.10415
  9. Ferlay J, Shin H, Bray F, et al (2008). GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 31/08/2012.
  10. Hansen J, Lassen CF (2012). Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med, 69, 551-6. https://doi.org/10.1136/oemed-2011-100240
  11. Hemminki K, Mousavi SM, Sundquist J, et al (2011). Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. Oncologist, 16, 146-54. https://doi.org/10.1634/theoncologist.2010-0104
  12. Howlader N, Noone A, Krapcho M, et al (2012). SEER cancer statistics review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/.
  13. Ingelman-Sundberg M (2004). Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci, 25, 193-200. https://doi.org/10.1016/j.tips.2004.02.007
  14. Jernstrom H, Chu W, Vesprini D, et al (2001). Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab, 72, 144-54. https://doi.org/10.1006/mgme.2000.3130
  15. Kurian AW, Fish K, Shema SJ, et al (2010). Lifetime risks of specific breast cancer subtypes among women in four racial/ ethnic groups. Breast Cancer Res, 12, 99. https://doi.org/10.1186/bcr2780
  16. Kwong A, Cheung P, Chan S, et al (2008). Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg, 32, 2554-61. https://doi.org/10.1007/s00268-008-9589-6
  17. Li J, Zhang BN, Fan JH, et al (2011). A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer, 11, 364. https://doi.org/10.1186/1471-2407-11-364
  18. Liu L, Zhang J, Wu AH, et al (2012). Invasive breast cancer incidence trends by detailed race/ethnicity and age. Int J Cancer, 130, 395-404. https://doi.org/10.1002/ijc.26004
  19. Manuwald U, Velasco Garrido M, Berger J, et al (2012). Mortality study of chemical workers exposed to dioxins: follow-up 23 years after chemical plant closure. Occup Environ Med, 69, 636-42. https://doi.org/10.1136/oemed-2012-100682
  20. Menes TS, Ozao J, Kim U (2007). Breast cancer and ethnicity: strong association between reproductive risk factors and estrogen receptor status in Asian patients - a retrospective study. Breast J, 13, 352-8. https://doi.org/10.1111/j.1524-4741.2007.00442.x
  21. Ooi SL, Martinez ME, Li CI (2011). Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat, 127, 729-38. https://doi.org/10.1007/s10549-010-1191-6
  22. Setiawan VW, Haiman CA, Stanczyk FZ, et al (2006). Racial/ ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 15, 1849-55. https://doi.org/10.1158/1055-9965.EPI-06-0307
  23. Tavassoli F, Devilee P (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC, 2003:221-32., Lyon, International Agency for Research on Cancer.
  24. Telli ML, Chang ET, Kurian AW, et al (2011). Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat, 127, 471-8. https://doi.org/10.1007/s10549-010-1173-8
  25. Thompson CL, Li L (2012). Association of sleep duration and breast cancer OncotypeDX recurrence score. Breast Cancer Res Treat, 134, 1291-5. https://doi.org/10.1007/s10549-012-2144-z
  26. Tilghman SL, Bratton MR, Segar HC, et al (2012). Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One, 7, 32754. https://doi.org/10.1371/journal.pone.0032754
  27. Villeneuve S, Cyr D, Lynge E, et al (2010). Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup Environ Med, 67, 837-44. https://doi.org/10.1136/oem.2009.052175
  28. Wang FL, Chen F, Yin H, et al (2013). Effects of age, breast density and volume on breast cancer diagnosis: a retrospective comparison of sensitivity of mammography and ultrasonography in China's rural areas. Asian Pac J Cancer Prev, 14, 2277-82. https://doi.org/10.7314/APJCP.2013.14.4.2277
  29. Wu LZ, Han RQ, Zhou JY, et al (2014). Incidence and mortality of female breast cancer in Jiangsu, China. Asian Pac J Cancer Prev, 15, 2727-32. https://doi.org/10.7314/APJCP.2014.15.6.2727
  30. Yi M, Liu P, Li X, et al (2012). Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer, 118, 4117-25. https://doi.org/10.1002/cncr.27399
  31. Zarbo RJ, Hammond ME (2003). Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice. Arch Pathol Lab Med, 127, 549-53.
  32. Zheng S, Bai JQ, Li J, et al (2012). The pathologic characteristics of breast cancer in China and its shift during 1999-2008: A national-wide multicenter cross-sectional image over 10 years. Int J Cancer, 131, 2622-31. https://doi.org/10.1002/ijc.27513

Cited by

  1. Breast Cancer Inpatients Undergoing Mastectomy from a Hospital in Guangzhou, China: A Retrospective Analysis 2004-2013 vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4577
  2. Estimation of cancer burden in Guangdong Province, China in 2009 vol.34, pp.3, 2015, https://doi.org/10.1186/s40880-015-0060-4
  3. Dissimilarity between sporadic, non-BRCA1/2 families and hereditary breast cancer, linked to BRCA genes, in the Tunisian population vol.23, pp.5, 2016, https://doi.org/10.1007/s12282-015-0648-1
  4. Female breast cancer burden was increasing during the 40 years in Hebei Province, China: a population-based study vol.294, pp.5, 2016, https://doi.org/10.1007/s00404-016-4149-z
  5. Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival vol.12, pp.6, 2017, https://doi.org/10.1371/journal.pone.0178850
  6. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women vol.26, pp.3, 2017, https://doi.org/10.1089/jwh.2015.5692
  7. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy vol.155, pp.1, 2018, https://doi.org/10.1186/s41065-018-0055-7
  8. 68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer vol.43, pp.9, 2018, https://doi.org/10.1097/RLU.0000000000002209